CSIMarket
 
Heartflow Inc   (NASDAQ: HTFL)
 

Heartflow Inc's Customers Performance

HTFL



 
HTFL's Source of Revenues During the corresponding time, Heartflow Inc recorded a revenue increase by 40.21 % year on year, sequentially revenue grew by 6.18 %. While revenue at the Heartflow Inc 's corporate clients

List of HTFL Customers




for the same period Heartflow Inc recorded revenue increase by 40.21 % year on year, sequentially revenue grew by 6.18 %.

List of HTFL Customers

Heartflow Inc's Business Units
United States    93.91 % of total Revenue
Rest of World    6.9 % of total Revenue






Heartflow Inc's Comment on Sales, Marketing and Customers



Heartflow provides services to hospitals and outpatient imaging centers performing coronary computed tomography angiography (CCTA) for patients with symptoms of coronary artery disease (CAD), in accordance with American Heart Association (AHA) and American College of Cardiology (ACC) chest pain guidelines. The Heartflow platform integrates into customer workflows to deliver Heartflow RoadMap Analysis to imaging cardiologists or radiologists, aiding in CCTA interpretation and treatment planning. Physicians use Heartflow analyses, including Heartflow FFR CT Analysis and Heartflow Plaque Analysis, to diagnose and manage CAD, with direct billing to the accounts. The Heartflow RoadMap Analysis, cleared by the FDA in October 2022 and available since the second quarter of 2023, supports radiology workflow by improving read times and consistency among physicians, functioning as a first-line assessment tool alongside CCTA interpretation.





Heartflow Inc’s Comment on Sales, Marketing and Customers


Heartflow provides services to hospitals and outpatient imaging centers performing coronary computed tomography angiography (CCTA) for patients with symptoms of coronary artery disease (CAD), in accordance with American Heart Association (AHA) and American College of Cardiology (ACC) chest pain guidelines. The Heartflow platform integrates into customer workflows to deliver Heartflow RoadMap Analysis to imaging cardiologists or radiologists, aiding in CCTA interpretation and treatment planning. Physicians use Heartflow analyses, including Heartflow FFR CT Analysis and Heartflow Plaque Analysis, to diagnose and manage CAD, with direct billing to the accounts. The Heartflow RoadMap Analysis, cleared by the FDA in October 2022 and available since the second quarter of 2023, supports radiology workflow by improving read times and consistency among physicians, functioning as a first-line assessment tool alongside CCTA interpretation.








HTFL's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Heartflow Inc 4,318.81 226.69 -204.22 843
SUBTOTAL 0.00 0.00 0.00 -

Sources: Heartflow Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Heartflow Inc’s corporate clients.
For your research, we’ve provided 9 tables on Heartflow Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.